ROBXF yields 2000000.00% · JNJ yields 2.13%● Live data
📍 ROBXF pulled ahead of the other in Year 1
Combined, ROBXF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ROBXF + JNJ for your $10,000?
Robix Environmental Technologies, Inc., an investment holding company, develops and sells oil spill response and recovery equipment, oil-water separation equipment, and cleaning and purification equipment in Canada. The company operates through Clean Ocean Vessel Technology and Clean Water Technology segments. Its products include C series clean ocean vessel that recover oil in rough ocean waters, lakes, rivers, and tailings ponds; and P series platform, which accelerates oil recovery from settling ponds at production facilities, as well as hydro cycle water systems. Robix Environmental Technologies, Inc. also provides contaminated water clean-up treatment services. The company was formerly known as Robix Alternative Fuels, Inc. and changed its name to Robix Environmental Technologies, Inc. in March 2016. Robix Environmental Technologies, Inc. was founded in 2011 and is headquartered in Calgary, Canada. Robix Environmental Technologies, Inc. is a subsidiary of Blue Horizon Industries Inc.
Full ROBXF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.